Quite right. Nebulised Relenza would be seperate and different to IV Relenza. I was simply making the point that there is so much demand for alternative delivery systems (whether nebulised or intravenous) for Relenza in intensive care patients who cannot use the standard device that docs have taken the desperate move of making up their own solutions as best they can. Interesting though that the docs who saved the life of the near death patient with IV Relenza that was written up in the Lancet recently initially used nebulised Relenza. I wonder where they got that from?
- Forums
- ASX - By Stock
- BTA
- fda, glaxo warn of death due to anti-flu medic
fda, glaxo warn of death due to anti-flu medic, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online